EZH2 and colorectal carcinoma: The contribution of EZH2 to CRC has been thoroughly discussed, and this protein is a prognostic and therapeutic target in CRC 52-54; our study confirmed the prognostic value of EZH2 in the OS and DFS of CRC patients.